Predictive biomarkers for checkpoint inhibitor-based immunotherapy

• Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes

  2026 Research and Practice in Thrombosis and Haemostasis article Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity

  2025 Immunity article Medicine Cancer Immunotherapy and Biomarkers

  7

  citations
• One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma

  2025 Clinical Cancer Research article Medicine Head and Neck Cancer Studies

  6

  citations
• High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma

  2024 European Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  13

  citations
• Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

  2023 Tumor Biology article Medicine Cancer Immunotherapy and Biomarkers Open access

  4

  citations
• Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma

  2023 Nature Reviews Clinical Oncology review Medicine Cutaneous Melanoma Detection and Management

  50

  citations
• Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma

  2023 iScience article Medicine Cancer Immunotherapy and Biomarkers Open access

  7

  citations
• Behavioral factors to modulate immunotherapy efficacy in cancer

  2022 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

  9

  citations
• Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

  2022 European Urology article Medicine Bladder and Urothelial Cancer Treatments Open access

  30

  citations
• Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer

  2021 Cells article Medicine Cancer Immunotherapy and Biomarkers Open access

  24

  citations
• Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer

  2021 Molecular Therapy — Oncolytics article Medicine Cancer Immunotherapy and Biomarkers Open access

  40

  citations
• Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy

  2021 European Journal of Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

  62

  citations
• Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives

  2020 Advanced Therapeutics article Medicine Cancer Immunotherapy and Biomarkers Open access

  98

  citations
• Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)

  2020 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access

  124

  citations
• Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer

  2020 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access

  20

  citations
• Current status of immunotherapy in gastrointestinal malignancies

  2020 Zeitschrift für Gastroenterologie article Medicine Cancer Immunotherapy and Biomarkers

  6

  citations

16 results